Tyche Industries Ltd Stock Price Today (NSE: TYCHE)
Fundamental Score
Tyche Industries Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Tyche Industries Ltd share price today is ₹99.80, up +0.00% on NSE/BSE as of 30 March 2026. Tyche Industries Ltd (TYCHE) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹124.08 (Cr). The 52-week high for TYCHE share price is ₹158.50 and the 52-week low is ₹100.00. At a P/E ratio of 12.88x, TYCHE is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 9.41% and a debt-to-equity ratio of 0.00.
Tyche Industries Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Tyche Industries Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Tyche Share Price: A Financial Stability Analysis
In the dynamic pharmaceutical industry, a sector known for its intense R&D investments and regulatory hurdles, understanding a company's financial health is paramount. This analysis focuses on the financial stability of Tyche Industries Ltd, specifically examining factors influencing the Tyche share price. Our assessment is based on a snapshot of key financial metrics and a comparative overview of its sector peers.
Currently, Tyche Industries Ltd. exhibits a price of ₹111.400002, a PE ratio of 12.88, and a Return on Capital Employed (ROCE) of 12.67%. While the PE ratio suggests the stock might be reasonably valued compared to its earnings, ROCE offers insight into how effectively the company is using its capital to generate profits. A ROCE of 12.67% indicates that Tyche is generating a respectable return on its investments, suggesting operational efficiency. This return contributes to the company's economic moat, representing a competitive advantage by hindering competitors.
When compared to its peers, such as
Mankind Pharma Ltd, differing management qualities can significantly impact shareholder value. While a direct comparison of management quality requires in-depth qualitative analysis, understanding leadership's vision and execution capabilities is vital. For example, Mankind Pharma Ltd has established itself as a very strong brand. Management of Tyche Industries would need to enhance brand visibility for the company to continue gaining strength.A deeper understanding of Tyche's financial health would require a comprehensive 80-parameter fundamental audit. This audit, verified by Sweta Mishra, would delve into aspects such as debt levels, cash flow, and future growth prospects. This analysis serves as an observational assessment of publicly available data and does not constitute investment advice. It provides a preliminary view of the factors influencing the Tyche share price.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Tyche Industries Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of TYCHE across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Strong Operating Margins (21.59%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 12.88 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Cash Generation (₹34.53 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (61.97%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
6 factors identified
Below-Average Return on Equity (9.41%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Profit Decline Concern (-66.30%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-31.06%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-2.34% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-6.73% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-6.73% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Tyche Industries Ltd Financial Statements
Comprehensive financial data for Tyche Industries Ltd including income statement, balance sheet and cash flow
About TYCHE (Tyche Industries Ltd)
Tyche Industries Ltd is a dynamic pharmaceutical entity operating on a global scale, specializing in the intricate development and production of critical pharmaceutical components.... The company's core competencies lie in the synthesis and distribution of high-quality Active Pharmaceutical Ingredients (APIs) and vital pharmaceutical intermediates. Beyond these essential elements, Tyche demonstrates a strong commitment to innovation, venturing into the creation of specialized chiral intermediates and the development of advanced nutraceutical products. This multifaceted approach positions TYCHE as a comprehensive provider for companies requiring diverse and specialized pharmaceutical inputs. Furthermore, TYCHE extends its expertise through comprehensive contract service offerings, providing end-to-end support to its partners. These services encompass drug substance development, rigorous analytical testing, and complete contract development and manufacturing (CDMO) solutions. This comprehensive suite of services allows client companies to leverage TYCHE's advanced facilities and seasoned experts to accelerate drug development and streamline the manufacturing process, from initial concept to final product. Its commitment to quality and scientific rigor has allowed the organization to build a solid reputation within the global pharmaceutical market. Strategically headquartered in Hyderabad, India, TYCHE leverages its advantageous location to effectively serve key international markets. While maintaining a significant presence within India, the company's reach extends predominantly to the discerning pharmaceutical sectors of the United States and Europe. TYCHE's strategic export focus underlines its dedication to meeting the stringent quality standards and regulatory requirements of these key regions. Since its inception in 1998, TYCHE has steadily grown, establishing itself as a reliable and trusted partner for pharmaceutical companies worldwide, providing essential components and invaluable services.
Company Details
Key Leadership
Corporate Events
Latest News
TYCHE Share Price: Frequently Asked Questions
What is the current share price of Tyche Industries Ltd (TYCHE)?
As of 30 Mar 2026, 12:04 pm IST, Tyche Industries Ltd share price is ₹99.80. The TYCHE stock has a market capitalisation of ₹124.08 (Cr) on NSE/BSE.
Is TYCHE share price Overvalued or Undervalued?
TYCHE share price is currently trading at a P/E ratio of 12.88x, compared to the industry average of 31.77x. Based on this relative valuation, the Tyche Industries Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of TYCHE share price?
The 52-week high of TYCHE share price is ₹158.50 and the 52-week low is ₹100.00. These values are updated daily from NSE/BSE price data.
What factors affect the Tyche Industries Ltd share price?
Key factors influencing TYCHE share price include quarterly earnings growth (Sales Growth: -31.06%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Tyche Industries Ltd a good stock for long-term investment?
Tyche Industries Ltd shows a 5-year Profit Growth of -6.73% and an ROE of 9.41%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing in TYCHE shares.
How does Tyche Industries Ltd compare with its industry peers?
Tyche Industries Ltd competes with major peers in the Pharmaceuticals. Investors should compare TYCHE share price P/E of 12.88x and ROE of 9.41% against the industry averages to determine competitive standing.
What is the P/E ratio of TYCHE and what does it mean?
TYCHE share price has a P/E ratio of 12.88x compared to the industry average of 31.77x. Investors pay ₹13 for every ₹1 of annual earnings.
How is TYCHE performing according to Bull Run's analysis?
TYCHE has a Bull Run fundamental score of 33.6/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does TYCHE belong to?
TYCHE operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Tyche Industries Ltd share price.
What is Return on Equity (ROE) and why is it important for TYCHE?
TYCHE has an ROE of 9.41%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Tyche Industries Ltd generates profits from shareholders capital.
How is TYCHE debt-to-equity ratio and what does it indicate?
TYCHE has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk.
What is TYCHE dividend yield and is it a good dividend stock?
TYCHE offers a dividend yield of 2.48%, meaning you receive ₹2.48 annual dividend for every ₹100 invested in Tyche Industries Ltd shares.
How has TYCHE share price grown over the past 5 years?
TYCHE has achieved 5-year growth rates of: Sales Growth -2.34%, Profit Growth -6.73%, and EPS Growth -6.73%.
What is the promoter holding in TYCHE and why does it matter?
Promoters hold 61.97% of TYCHE shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Tyche Industries Ltd.
What is TYCHE market capitalisation category?
TYCHE has a market capitalisation of ₹124 crores, placing it in the Small-cap category.
How volatile is TYCHE stock?
TYCHE has a beta of N/A. A beta > 1 suggests the Tyche Industries Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is TYCHE operating profit margin trend?
TYCHE has a 5-year average Operating Profit Margin (OPM) of 21.59%, indicating the company's operational efficiency.
How is TYCHE quarterly performance?
Recent quarterly performance shows Tyche Industries Ltd YoY Sales Growth of -31.06% and YoY Profit Growth of -66.30%.
What is the institutional holding pattern in TYCHE?
TYCHE has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Tyche Industries Ltd stock.